PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.7600
+0.0053 (0.70%)
Apr 25, 2025, 4:00 PM EDT - Market closed

PAVmed Statistics

Total Valuation

PAVmed has a market cap or net worth of $23.68 million. The enterprise value is $54.01 million.

Market Cap 23.68M
Enterprise Value 54.01M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

PAVmed has 31.16 million shares outstanding. The number of shares has increased by 802.87% in one year.

Current Share Class 31.16M
Shares Outstanding 31.16M
Shares Change (YoY) +802.87%
Shares Change (QoQ) +196.70%
Owned by Insiders (%) 4.72%
Owned by Institutions (%) 3.43%
Float 27.12M

Valuation Ratios

The trailing PE ratio is 1.53.

PE Ratio 1.53
Forward PE n/a
PS Ratio 2.45
Forward PS 78.71
PB Ratio -3.37
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 1.69
EV / Sales 18.03
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio 0.06
Quick Ratio 0.04
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -988.60

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -87.19%
Return on Invested Capital (ROIC) -112.26%
Return on Capital Employed (ROCE) 929.52%
Revenue Per Employee $76,795
Profits Per Employee $819,641
Employee Count 39
Asset Turnover 0.09
Inventory Turnover 12.02

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.92% in the last 52 weeks. The beta is 1.14, so PAVmed's price volatility has been higher than the market average.

Beta (5Y) 1.14
52-Week Price Change -58.92%
50-Day Moving Average 0.72
200-Day Moving Average 0.89
Relative Strength Index (RSI) 56.48
Average Volume (20 Days) 129,913

Short Selling Information

The latest short interest is 237,355, so 0.76% of the outstanding shares have been sold short.

Short Interest 237,355
Short Previous Month 385,503
Short % of Shares Out 0.76%
Short % of Float 0.88%
Short Ratio (days to cover) 1.44

Income Statement

In the last 12 months, PAVmed had revenue of $3.00 million and earned $31.97 million in profits. Earnings per share was $0.50.

Revenue 3.00M
Gross Profit -1.85M
Operating Income -44.49M
Pretax Income -61.46M
Net Income 31.97M
EBITDA -43.29M
EBIT -44.49M
Earnings Per Share (EPS) $0.50
Full Income Statement

Balance Sheet

The company has $1.53 million in cash and $31.86 million in debt, giving a net cash position of -$30.33 million or -$0.97 per share.

Cash & Cash Equivalents 1.53M
Total Debt 31.86M
Net Cash -30.33M
Net Cash Per Share -$0.97
Equity (Book Value) -7.03M
Book Value Per Share -0.52
Working Capital -33.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.55 million and capital expenditures -$55,000, giving a free cash flow of -$33.61 million.

Operating Cash Flow -33.55M
Capital Expenditures -55,000
Free Cash Flow -33.61M
FCF Per Share -$1.08
Full Cash Flow Statement

Margins

Gross margin is -61.60%, with operating and profit margins of -1,485.38% and 1,328.58%.

Gross Margin -61.60%
Operating Margin -1,485.38%
Pretax Margin 949.15%
Profit Margin 1,328.58%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PAVmed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -802.87%
Shareholder Yield n/a
Earnings Yield 134.97%
FCF Yield -141.91%
Dividend Details

Analyst Forecast

The average price target for PAVmed is $19.50, which is 2,465.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target $19.50
Price Target Difference 2,465.79%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 153.17%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 7, 2023. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Dec 7, 2023
Split Type Reverse
Split Ratio 0.0666667:1

Scores

PAVmed has an Altman Z-Score of -17.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -17.41
Piotroski F-Score 3